Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $16,334 - $23,487
449 Added 1.84%
24,857 $1.03 Million
Q4 2023

Feb 13, 2024

SELL
$14.19 - $42.33 $1,404 - $4,190
-99 Reduced 0.4%
24,408 $1 Million
Q3 2023

Nov 13, 2023

BUY
$19.64 - $28.21 $17,126 - $24,599
872 Added 3.69%
24,507 $481,000
Q2 2023

Aug 04, 2023

BUY
$21.73 - $31.43 $3,411 - $4,934
157 Added 0.67%
23,635 $586,000
Q1 2023

May 12, 2023

BUY
$26.15 - $37.26 $12,238 - $17,437
468 Added 2.03%
23,478 $641,000
Q4 2022

Feb 10, 2023

SELL
$32.47 - $57.24 $2,727 - $4,808
-84 Reduced 0.36%
23,010 $787,000
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $13,691 - $18,962
327 Added 1.44%
23,094 $1.03 Million
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $22,398 - $46,177
-622 Reduced 2.66%
22,767 $958,000
Q1 2022

May 13, 2022

SELL
$60.27 - $81.57 $99,204 - $134,264
-1,646 Reduced 6.57%
23,389 $1.57 Million
Q4 2021

Feb 11, 2022

BUY
$65.85 - $96.21 $75,398 - $110,160
1,145 Added 4.79%
25,035 $2.06 Million
Q3 2021

Nov 12, 2021

SELL
$73.2 - $107.87 $41,577 - $61,270
-568 Reduced 2.32%
23,890 $1.96 Million
Q2 2021

Aug 13, 2021

BUY
$60.45 - $84.26 $204,139 - $284,546
3,377 Added 16.02%
24,458 $1.88 Million
Q1 2021

May 07, 2021

BUY
$58.19 - $91.37 $57,666 - $90,547
991 Added 4.93%
21,081 $1.39 Million
Q4 2020

Feb 12, 2021

BUY
$20.19 - $84.93 $52,534 - $220,987
2,602 Added 14.88%
20,090 $1.71 Million
Q3 2020

Nov 04, 2020

SELL
$22.99 - $36.34 $9,150 - $14,463
-398 Reduced 2.23%
17,488 $413,000
Q2 2020

Aug 12, 2020

BUY
$29.88 - $56.74 $159,200 - $302,310
5,328 Added 42.43%
17,886 $600,000
Q1 2020

May 04, 2020

SELL
$33.0 - $54.5 $23,958 - $39,567
-726 Reduced 5.47%
12,558 $506,000
Q4 2019

Feb 05, 2020

BUY
$15.39 - $44.38 $26,101 - $75,268
1,696 Added 14.64%
13,284 $546,000
Q3 2019

Nov 08, 2019

BUY
$21.55 - $27.61 $8,663 - $11,099
402 Added 3.59%
11,588 $250,000
Q2 2019

Aug 13, 2019

BUY
$15.96 - $23.8 $99,430 - $148,274
6,230 Added 125.71%
11,186 $246,000
Q1 2019

May 06, 2019

SELL
$13.55 - $23.79 $2,181 - $3,830
-161 Reduced 3.15%
4,956 $73,000
Q4 2018

Feb 13, 2019

BUY
$11.19 - $18.56 $57,259 - $94,971
5,117 New
5,117 $66,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.